• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Home
  • Latest
  • Videos
  • Series
  • E-Newsletters
    • Fat Tail Daily
    • James Cooper’s Mining Memo
    • The Daily Reckoning Australia
  • Categories
    • Commodities
    • Macro
    • Market Analysis
    • Small Caps
    • Technology
  • Investment Guides
  • Premium Services
  • Editors
  • About
  • Contact Us
Fat Tail Daily
Subscribe
  • Home
  • Latest
  • Videos
  • E-Newsletters
  • Premium Services

Kiryll Prakapenka

Nanosonics Share Price Flat on Business Update

Nanosonics Share Price Flat on Business Update

Healthcare stock Nanosonics [ASX:NAN] announced a transition to a direct sales model in North America.

By Kiryll Prakapenka, Wednesday, 25 May 2022

TechnologyOne [ASX:TNE] Shares Flat Despite Record H1 FY22 Profit

TechnologyOne [ASX:TNE] Shares Flat Despite Record H1 FY22 Profit

Enterprise SaaS stock TechnologyOne [ASX:TNE] has released its half-year results, notching its 13th year of ‘record first half profit’.

By Kiryll Prakapenka, Tuesday, 24 May 2022

BrainChip [ASX:BRN] Shares Dip on Annual General Meeting

BrainChip [ASX:BRN] Shares Dip on Annual General Meeting

AI tech developer BrainChip Holdings [ASX:BRN] released its annual general meeting CEO and chairman’s address on Tuesday as shares dipped.

By Kiryll Prakapenka, Tuesday, 24 May 2022

The Future of Growth Stocks: Is It Bleak?

The Future of Growth Stocks: Is It Bleak?

In today’s Money Morning…growth funds take a hit…a lost decade for stocks?…distinguishing value from price…and much more…

By Kiryll Prakapenka, Tuesday, 24 May 2022

Incitec Update: Record Performance and Business Split Announced

Incitec Update: Record Performance and Business Split Announced

Incitec Pivot [ASX:IPL] enjoyed a ‘record’ first-half performance due to an upswing in commodities.

By Kiryll Prakapenka, Monday, 23 May 2022

Imugene [ASX:IMU] Shares Rise as Management Seeks to Reassure Shareholders

Imugene [ASX:IMU] Shares Rise as Management Seeks to Reassure Shareholders

Australian immune-oncology stock Imugene [ASX:IMU] released a letter this morning addressing shareholder discontent at the recent share price decline.

By Kiryll Prakapenka, Monday, 23 May 2022

Pilbara Minerals [ASX:PLS] and Calix Shares Rise on $20M Grant

Pilbara Minerals [ASX:PLS] and Calix Shares Rise on $20M Grant

Pilbara Minerals [ASX:PLS] today announced the receipt of a $20 million grant alongside Calix Ltd [ASX:CXL].

By Kiryll Prakapenka, Tuesday, 17 May 2022

Openpay and Sezzle Shares Fall on Trading Updates

Openpay and Sezzle Shares Fall on Trading Updates

ASX BNPL stocks Openpay Group [ASX:OPY] and Sezzle Inc [ASX:SZL] both fell on Tuesday after releasing trading updates.

By Kiryll Prakapenka, Tuesday, 17 May 2022

What Next for Stocks as Pandemic Euphoria Fades?

What Next for Stocks as Pandemic Euphoria Fades?

In today’s Money Morning…retail investors surpass hedge funds…‘wacked-out, Fed-fuelled market’ ends…the sell-off asking investors serious questions…stock market’s goalposts have changed: profit back on the menu…and more…

By Kiryll Prakapenka, Tuesday, 17 May 2022

Calix and Boral Secure $30 Million for Carbon Abatement Project

Calix and Boral Secure $30 Million for Carbon Abatement Project

Calix [ASX:CXL] and Boral [ASX:BLD] announced they have received $30 million in government funding for a joint carbon abatement project.

By Kiryll Prakapenka, Monday, 16 May 2022

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Interim pages omitted …
  • Page 67
  • Go to Next Page »

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988